| abstract |
The invention relates to a pharmaceutical formulation, e.g. a paediatric formulation,of odevixibat, which comprises a plurality of small particles. The formulation may be used in the treatment ofliver diseases such as bile acid-dependent liver diseases, and particularly cholestatic liver diseases such as biliary atresia,progressive familial intrahepatic cholestasis (PFIC), Alagille syndrome (ALGS) and paediatric cholestatic pruritus. The invention also relates to a process for the preparation of the pharmaceutical formulation. |